NCT03798834

Brief Summary

The fascia iliaca block (FIB) is an anterior approach to block the lumbar plexus. It disturbed mainly to the anterior region of the thigh by blocking the femoral nerve (LFC) and the lateral femoral cutaneous nerve. Moreover, FIB may possibly be extended to the obturator, ilioinguinal, genitofemoral, lateral cutaneous nerve of the thigh and over the psoas muscle but, rarely reaches the lumbar plexus. The fascia iliaca compartment could be detected by bony landmarks palpation and the loss of resistance technique. Feeling two tactile ''pops'' due to loss of resistance occurred during the needle passage through the fascia lata and the fascia iliaca. Ultrasound (US) guidance of FIB will increase the success rate and the efficacy of sensory blockade by decreasing the needed local anesthetic amount.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 17, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 8, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 10, 2019

Completed
22 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2019

Completed
Last Updated

September 22, 2020

Status Verified

September 1, 2020

Enrollment Period

3 months

First QC Date

January 8, 2019

Last Update Submit

September 19, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • The proportion of the patients who did not require conversion to general anesthesia

    for 30 minutes

Secondary Outcomes (6)

  • Postoperative pain

    For 24 hours after the intervention

  • Heart rate

    For 6 hours after the intervention

  • mean arterial pressure (MAP

    For 6 hours after the intervention

  • hypotension

    For 24 hours from the block

  • Any observed adverse effects

    over the 24 hours postoperative

  • +1 more secondary outcomes

Study Arms (2)

Fascia iliaca block (FIB)

EXPERIMENTAL

ultrasound-guided Fascia iliaca block

Drug: Fascia iliaca block (FIB)

Spinal anesthesia

PLACEBO COMPARATOR

Spinal anaesthesia using 2 ml hyperbaric bupivacaine 0.5%

Other: Spinal anesthesia

Interventions

ultrasound-guided Fascia iliaca block

Fascia iliaca block (FIB)

Spinal anaesthesia using 2 ml hyperbaric bupivacaine 0.5%

Spinal anesthesia

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA physical status I or II.

You may not qualify if:

  • Patients with previous same lower limb surgery
  • Neuromuscular disease
  • Severe cardiovascular disease
  • Any contraindications to regional anesthesia
  • patient refusal
  • coagulation abnormality
  • Known allergy to local anesthetics
  • Infection at the injection site

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura University

Al Mansurah, DK, 050, Egypt

Location

MeSH Terms

Interventions

Anesthesia, Spinal

Intervention Hierarchy (Ancestors)

Anesthesia, ConductionAnesthesiaAnesthesia and Analgesia

Study Officials

  • Reem A Elsharkawy, MD

    Lecturer of Anesthesia and Surgical Intensive Care

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 8, 2019

First Posted

January 10, 2019

Study Start

November 17, 2018

Primary Completion

February 1, 2019

Study Completion

April 15, 2019

Last Updated

September 22, 2020

Record last verified: 2020-09

Locations